Osilodrostat for the treatment of Cushing's disease: efficacy, stability, and persistence. Issue 6 (June 2022)

Record Type:: Journal Article
Title:: Osilodrostat for the treatment of Cushing's disease: efficacy, stability, and persistence. Issue 6 (June 2022)
Main Title:: Osilodrostat for the treatment of Cushing's disease: efficacy, stability, and persistence
Authors:: Chabre, Olivier
Muller, Marie
Cristante, Justine
Cracowski, Jean-Luc
Gay, Emmanuel
Abstract:
Is Part Of:: Lancet. Volume 10:Issue 6(2022)
Journal:: Lancet
Issue:: Volume 10:Issue 6(2022)
Issue Display:: Volume 10, Issue 6 (2022)
Year:: 2022
Volume:: 10
Issue:: 6
Issue Sort Value:: 2022-0010-0006-0000
Page Start:: 384
Page End:: 385
Publication Date:: 2022-06
Subjects:: Diabetes -- Periodicals
Endocrinology -- Periodicals
Endocrine glands -- Diseases -- Periodicals
616.4
Journal URLs:: http://www.sciencedirect.com/ ↗
DOI:: 10.1016/S2213-8587(22)00134-6 ↗
Languages:: English
ISSNs:: 2213-8587
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5146.080050
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 21493.xml